CAS 1883602-20-7

TES-991

CAS: 1883602-20-7

TES-991 is a reactive, inflammatory disease that belongs to the class of sirtuin inhibitors. It is a synthetic compound that has been shown to be effective against a range of diseases such as cardiovascular disorders, type 2 diabetes, and cancer. TES-991 inhibits the activity of SIRT1, which is an enzyme that regulates metabolism and inflammation. TES-991 is able to inhibit the production of fatty acids in cells by interfering with the synthesis of long chain polyunsaturated fatty acids (PUFA) in mitochondria. TES-991 also inhibits mitochondrial DNA mutation by binding to one or more molecular targets in mitochondria and preventing them from being activated by reactive oxygen species. This drug has been shown to be effective in animal models of spontaneous caenorhabditis elegans (Ce), cisplatin-induced Ce, and genetic Ce.

Formula: C₁₇H₁₁N₇OS₂

Purity: Min. 95%

Molecular weight: 393.5 g/mol

Ref: 3D-IAD60220

TES-991

CAS: 1883602-20-7

TES-991 is a potent and selective inhibitor of human α Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD)(IC50 of 3 nM).

Formula: C₁₇H₁₁N₇OS₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 393.45

Ref: TM-T13132